• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液学患者单采血小板输注治疗效果的列线图

Nomogram for the Therapeutic Efficacy of Apheresis Platelet Transfusion in Hematologic Patients.

作者信息

He Yiwen, Feng Huihui, Yu Lu, Deng Gang

机构信息

Department of Blood Transfusion, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010 China.

Institute of Blood Transfusion, Ningbo Blood Center, Ningbo, 315010 China.

出版信息

Indian J Hematol Blood Transfus. 2025 Jul;41(3):656-664. doi: 10.1007/s12288-024-01857-0. Epub 2024 Sep 11.

DOI:10.1007/s12288-024-01857-0
PMID:40687467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12267762/
Abstract

UNLABELLED

This study aims to explore the factors that affect the efficacy of apheresis platelet transfusion in patients with hematologic diseases and construct a nomogram prediction model to predict the possibility of obtaining satisfactory platelet transfusion efficacy and guide scientific and rational platelet transfusion. The basic information of 2,007 hematologic patients who received apheresis platelet transfusions from June 2022 to April 2023 and the corresponding donor information and apheresis platelet data are collected. The risk factors that cause ineffective platelet transfusions are screened through a logistic regression analysis. Then, the risk factors are introduced into R software, and a nomogram prediction model is established and validated. The regression analysis shows that the independent risk factors for ineffective platelet transfusion are platelet count before transfusion, white blood cell count, hemoglobin content and mean corpuscular hemoglobin, cumulative platelet transfusion times, platelet antibody positivity, fever, splenomegaly, graft-versus-host disease, bleeding, and platelet storage days. These factors are included in the nomogram, and the calibration curve for predicting transfusion efficiency reveals good consistency between the nomogram-predicted results and the actual observations. The area under the curve obtained through internal repeated sampling is 0.756. This study comprehensively assessed the risks associated with factors leading to ineffective platelet transfusion and successfully constructed and validated a nomogram prediction model. This model provides an important predictive tool for assessing the efficacy of platelet transfusion in patients with hematologic diseases, with the potential to guide scientific and rational platelet transfusion practices.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12288-024-01857-0.

摘要

未标注

本研究旨在探讨影响血液系统疾病患者单采血小板输注疗效的因素,并构建列线图预测模型,以预测获得满意血小板输注疗效的可能性,指导科学合理的血小板输注。收集了2007例在2022年6月至2023年4月接受单采血小板输注的血液系统疾病患者的基本信息、相应的供者信息及单采血小板数据。通过逻辑回归分析筛选出导致血小板输注无效的危险因素。然后,将这些危险因素引入R软件,建立并验证列线图预测模型。回归分析显示,血小板输注无效的独立危险因素为输血前血小板计数、白细胞计数、血红蛋白含量及平均红细胞血红蛋白含量、累计血小板输注次数、血小板抗体阳性、发热、脾肿大、移植物抗宿主病、出血及血小板储存天数。这些因素被纳入列线图,预测输血效率的校准曲线显示列线图预测结果与实际观察结果具有良好的一致性。通过内部重复抽样获得的曲线下面积为0.756。本研究全面评估了导致血小板输注无效的因素相关风险,并成功构建和验证了列线图预测模型。该模型为评估血液系统疾病患者血小板输注疗效提供了重要的预测工具,有可能指导科学合理的血小板输注实践。

补充信息

在线版本包含可在10.1007/s12288-024-01857-0获取的补充材料。

相似文献

1
Nomogram for the Therapeutic Efficacy of Apheresis Platelet Transfusion in Hematologic Patients.血液学患者单采血小板输注治疗效果的列线图
Indian J Hematol Blood Transfus. 2025 Jul;41(3):656-664. doi: 10.1007/s12288-024-01857-0. Epub 2024 Sep 11.
2
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.比较不同血小板计数阈值,以指导预防性血小板输注的应用,从而预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后发生出血。
Cochrane Database Syst Rev. 2015 Nov 18;2015(11):CD010983. doi: 10.1002/14651858.CD010983.pub2.
3
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
4
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
5
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.一种仅用于治疗与预防性血小板输注策略,用于预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后出血。
Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD010981. doi: 10.1002/14651858.CD010981.pub2.
6
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.不同剂量预防性血小板输注对预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后出血的作用
Cochrane Database Syst Rev. 2015 Oct 27;2015(10):CD010984. doi: 10.1002/14651858.CD010984.pub2.
7
Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.在腰椎穿刺或硬膜外麻醉前使用血小板输注以预防血小板减少症患者的并发症。
Cochrane Database Syst Rev. 2018 Apr 30;4(4):CD011980. doi: 10.1002/14651858.CD011980.pub3.
8
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2017 Jul 30;7(7):CD009072. doi: 10.1002/14651858.CD009072.pub3.
9
Analysis of Risk Factors for Perioperative Transfusion in Hip Arthroplasty and Modeling of a Nomogram.髋关节置换术中围手术期输血的危险因素分析及列线图模型构建
Ann Ital Chir. 2025 Jul 10;96(7):956-966. doi: 10.62713/aic.4077.
10
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.用于预防慢性骨髓衰竭所致血小板减少症患者出血的预防性血小板输注替代药物:一项荟萃分析和系统评价
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD012055. doi: 10.1002/14651858.CD012055.pub2.

本文引用的文献

1
Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics.免疫性血小板输注无效:从机制到治疗的最新认识。
Platelets. 2024 Dec;35(1):2306983. doi: 10.1080/09537104.2024.2306983. Epub 2024 Feb 5.
2
Machine Learning Radiomics Liver Function Model for Prognostic Prediction After Radical Resection of Advanced Gastric Cancer: A Retrospective Study.机器学习放射组学肝功能模型在晚期胃癌根治性切除术后预后预测中的应用:一项回顾性研究。
Ann Surg Oncol. 2024 Mar;31(3):1749-1759. doi: 10.1245/s10434-023-14619-5. Epub 2023 Dec 19.
3
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients.
供受者性别与危重症患者输血相关结局有关。
Blood Adv. 2022 Jun 14;6(11):3260-3267. doi: 10.1182/bloodadvances.2021006402.
4
Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications.急性髓系白血病干细胞:起源、特征及临床意义。
Stem Cell Rev Rep. 2022 Apr;18(4):1211-1226. doi: 10.1007/s12015-021-10308-6. Epub 2022 Jan 20.
5
Assessment of apheresis platelets during 5 days of storage: A National Cancer Institute, Cairo University experience.5 天存储期内的机采血小板评估:开罗大学国家癌症研究所的经验。
Transfus Apher Sci. 2022 Apr;61(2):103327. doi: 10.1016/j.transci.2021.103327. Epub 2021 Nov 25.
6
Platelet transfusion improves clot formation and platelet function in severely thrombocytopenic haematology patients.血小板输注可改善严重血小板减少症血液病患者的凝血形成和血小板功能。
Br J Haematol. 2022 Jan;196(1):224-233. doi: 10.1111/bjh.17820. Epub 2021 Sep 16.
7
Platelet transfusion refractoriness: how do I diagnose and manage?血小板输注无效:如何诊断和处理?
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):527-532. doi: 10.1182/hematology.2020000137.
8
Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion.非同种免疫性血小板减少症和血小板输注无效的机制。
Transfus Med Rev. 2020 Oct;34(4):242-249. doi: 10.1016/j.tmrv.2020.09.002. Epub 2020 Sep 17.
9
A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.用于预测 COVID-19 合并实体瘤患者死亡率的列线图:一项多中心回顾性队列研究。
J Immunother Cancer. 2020 Sep;8(2). doi: 10.1136/jitc-2020-001314.
10
Platelet transfusion: Alloimmunization and refractoriness.血小板输注:同种免疫与难治性。
Semin Hematol. 2020 Apr;57(2):92-99. doi: 10.1053/j.seminhematol.2019.10.001. Epub 2019 Nov 8.